Learn More
Medchemexpress LLC Bebt-109 | 2050906-40-4 | 98.6% | 516.59 g·mol⁻¹ | C27H32N8O3 | 100 MG

Supplier: Medchemexpress LLC HYW423595100MG
BEBT-109 is a research-grade, pan-mutant-selective epidermal growth factor receptor (EGFR) inhibitor designed for preclinical studies of mutant EGFR-driven non-small cell lung cancer. It is supplied as a white to off-white solid with a molecular formula of C27H32N8O3, molecular weight 516.59 g·mol⁻¹, and a reported purity of approximately 98.6%.
- Pan-mutant-selective EGFR inhibitor for mutant EGFR-driven NSCLC research.
- High reported purity suitable for biochemical and cellular assays.
- Supplied as a stable solid for convenient storage and handling.
- Documented storage conditions support long-term sample integrity.
- Characterized molecular properties aid reproducible experimental design.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.